nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia
|
Kobayashi, Yukio |
|
2017 |
66 |
7 |
p. 851-863 |
artikel |
2 |
Cancer immunotherapy: how low-level ionizing radiation can play a key role
|
Janiak, Marek K. |
|
2017 |
66 |
7 |
p. 819-832 |
artikel |
3 |
Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow “in situ tumor vaccination”?
|
Deplanque, Gaël |
|
2017 |
66 |
7 |
p. 833-840 |
artikel |
4 |
Coexpressed modular gene expression reveals inverse correlation between immune responsive transcription and aggressiveness in gastric tumours
|
Kalamohan, Kalaivani |
|
2017 |
66 |
7 |
p. 941-954 |
artikel |
5 |
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
|
Gezgin, Gülçin |
|
2017 |
66 |
7 |
p. 903-912 |
artikel |
6 |
HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients
|
Dunne, Margaret R. |
|
2017 |
66 |
7 |
p. 841-850 |
artikel |
7 |
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
|
Melief, Sara M. |
|
2017 |
66 |
7 |
p. 913-926 |
artikel |
8 |
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
|
Okita, Riki |
|
2017 |
66 |
7 |
p. 865-876 |
artikel |
9 |
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
|
Lilleby, Wolfgang |
|
2017 |
66 |
7 |
p. 891-901 |
artikel |
10 |
Professor Enrico Mihich, 1928–2016
|
Pawelec, Graham |
|
2017 |
66 |
7 |
p. 955-957 |
artikel |
11 |
Prognostic implication of CD274 (PD-L1) protein expression in tumor-infiltrating immune cells for microsatellite unstable and stable colorectal cancer
|
Lee, Kyu Sang |
|
2017 |
66 |
7 |
p. 927-939 |
artikel |
12 |
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy
|
Nagato, Toshihiro |
|
2017 |
66 |
7 |
p. 877-890 |
artikel |